A country-by-country guide for pharmaceutical executives, generic manufacturers, and IP professionals operating across 54 markets The Patent Map Nobody Prints […]
Drug Patents in Africa: Exactly How Long They Last Read Post »
How to conduct a freedom-to-operate analysis that holds up in court, survives investor due diligence, and actually protects your pipeline
An Investigative Analysis of Pharmaceutical and Biotech Valuation Frameworks Why Most Biotech Valuations Get It Wrong Every quarter, analysts revise
Value a Biotech Like a Pro: The Metrics That Actually Move Price Targets Read Post »
What You Actually Need to Know About the Dual Shield Most people conflate drug patents with drug exclusivity. They are
How generic drug companies legally exploit the Hatch-Waxman framework to generate billion-dollar windfalls — and how brand manufacturers fight back
The Patent Clock Nobody Shows You The standard answer to “how long does a patent last?” is 20 years. You
20 Years on Paper: The Real Guide to Drug Patent Duration in the United States Read Post »
How payers, PBMs, and formulary committees can convert LOE intelligence into measurable cost savings — and why most of them
A Practical Guide to Tracking Competitors’ R&D Pipelines Before They Make Headlines The Intelligence Gap That Costs Billions Every pharmaceutical
The Decision That Defines Decades of Revenue Somewhere between the FDA approval notice hitting a pharmaceutical company’s inbox and the
Get fresh news and insights, drug patent expirations & more…
